Add BrightSurf on Google Email

High-volume antibody testing platform could accelerate disease research and treatment development

Researchers developed a high-volume method to rapidly build and test large numbers of antibodies at once, accelerating antibody research and treatment development. The oPool+ display platform has potential applications in influenza vaccination research, infectious disease treatment, and cancer research.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalScience Translational Medicine·TypeExperimental study·DateSep 3, 2025

Acquired immunity against random food allergens may protect some lucky people against COVID-19

A recent study finds that exposure to proteins in common foods, vaccines, bacteria, and viruses can prime the immune system to attack SARS-CoV-2, potentially providing protection against COVID-19. The study's findings suggest that individuals with a history of exposure to these agents may be less susceptible to severe illness.

SourceFrontiers·JournalFrontiers in Immunology·TypeExperimental study·DateSep 23, 2022